CCR7 and neoplasm: In addition, the proportion of CD8+ T cells was expressed higher in OSCC tumor tissues from CCR7-deficient mice, suggesting that CCR7 may promote tumor growth by inhibiting the activation of initial CD8+ T cells, thereby affecting the proliferation and replenishment of antitumor immune CD8+ T cells (54).